Global Information
회사소개 | 문의 | 비교리스트

유럽의 말초혈관 기기 시장(2020-2026년)

Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite

리서치사 iData Research Inc.
발행일 2020년 04월 상품 코드 937772
페이지 정보 영문 914 Pages
가격
US $ 13,995 ₩ 16,768,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄는 불가능합니다.
US $ 15,495 ₩ 18,566,000 PDF by E-mail (Site License) help
동일 사업장 내에서 공유하여 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 16,995 ₩ 20,363,000 PDF by E-mail (Corporate License) help
동일 기업의 모든 분이 이용할 수 있는 글로벌 라이선스입니다. 이용 인원수에 제한은 없습니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



유럽의 말초혈관 기기 시장(2020-2026년) Peripheral Vascular Devices Market Report Suite | Europe | 2020-2026 | MedSuite
발행일 : 2020년 04월 페이지 정보 : 영문 914 Pages

유럽의 말초혈관 기기 시장은 2019년 약 13억 유로에서 2026년까지 약 16억 유로에 달하고, 예측기간 동안 연평균 복합 성장률(CAGR)은 2.9%를 나타낼 것으로 예측됩니다.

유럽의 말초혈관 기기(Peripheral Vascular Devices) 시장에 대해 조사 분석했으며, 시장 분석(판매 수량, 평균판매가격(ASP), 매출, 성장률 동향), 시장 성장 촉진요인 및 저해요인, 경쟁 분석, 최근의 인수합병(M&A) 등에 대해 체계적인 정보를 전해드립니다.

목차

FIGURE 리스트

CHART 리스트

개요

유럽의 말초혈관 기기 시장 개요

경쟁 분석

시장 동향

시장의 발전

시술 건수

대상 시장

VERSION HISTORY

조사 방법

질환 개요

  • 기본 구조
  • 질병 치료 및 진단
  • 환자 인구 통계

제품 포트폴리오

  • 서론
  • 제품 포트폴리오
  • 규제 문제와 리콜
  • 임상시험

말초혈관 기기 시장 개요

  • 서론
    • 죽상경화증
    • 말초동맥질환(PAD)
  • 환율
  • 시장 개요
  • 동향 분석
  • 시장 성장 촉진요인 및 저해요인
    • 시장 성장 촉진요인
    • 시장 성장 저해요인
  • 경쟁사의 시장 점유율 분석
  • 기업 개요
  • SWOT 분석
  • 인수합병(M&A)

국가별 개요

  • 서론
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 베네룩스 국가
  • 북유럽 국가
  • 오스트리아
  • 스위스
  • 포르투갈

시술 건수

  • 시술
LSH 20.06.16

LIST OF FIGURES

For a Full Figure List, please Contact Global Information.

  • Figure 1-1: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (1 of 4) 4
  • Figure 1-2: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (2 of 4) 5
  • Figure 1-3: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (3 of 4) 5
  • Figure 1-4: Peripheral Vascular Device Competitor Market Share Ranking by Segment, Europe, 2019 (4 of 4) 5
  • Figure 1-5: Companies Researched in this Report, Europe, 2019 (1 of 2) 7
  • Figure 1-6: Companies Researched in this Report, Europe, 2019 (2 of 2) 8
  • Figure 1-7: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (1 of 4) 9
  • Figure 1-8: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (2 of 4) 10
  • Figure 1-9: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (3 of 4) 11
  • Figure 1-10: Factors Impacting the Peripheral Vascular Device Market by Segment, Europe (4 of 4) 12
  • Figure 1-11: Recent Events in the Peripheral Vascular Device Market, European, 2016 - 2019 13
  • Figure 1-12: Peripheral Vascular Procedures Covered, Europe, 2019 (1 of 2) 14
  • Figure 1-13: Peripheral Vascular Procedures Covered, Europe, 2019 (2 of 2) 15
  • Figure 1-14: Peripheral Vascular Device Markets Covered, Europe, 2019 (1 of 2) 16
  • Figure 1-15: Peripheral Vascular Device Markets Covered, Europe, 2019 (2 of 2) 17
  • Figure 1-16: Version History 18
  • Figure 3-1: Peripheral Vascular Stent by Company (1 of 2) 44
  • Figure 3-2: Peripheral Vascular Stent by Company (2 of 2) 45
  • Figure 3-3: Venous Stent by Company 46
  • Figure 3-4: PTA Balloon Catheter by Company (1 of 3) 48
  • Figure 3-5: PTA Balloon Catheter by Company (2 of 3) 49
  • Figure 3-6: PTA Balloon Catheter by Company (3 of 3) 50
  • Figure 3-7: Drug-Coated Balloon by Company 52
  • Figure 3-8: Atherectomy Device by Company 54
  • Figure 3-9: Chronic Total Occlusion Device by Company 56
  • Figure 3-10: Lithotripsy Device by Company 57
  • Figure 3-11: Surgical Graft by Company (1 of 2) 59
  • Figure 3-12: Surgical Graft by Company (2 of 2) 60
  • Figure 3-13: Stent Graft by Company 62
  • Figure 3-14: Embolic Protection Device by Company 64
  • Figure 3-15: Peripheral Thrombus Management by Company 67
  • Figure 3-16: Inferior Vena Cava Filter by Company 68
  • Figure 3-17: Carotid Shunt by Company 69
  • Figure 3-18: Diagnostic and Interventional Catheters by Company (1 of 2) 71
  • Figure 3-19: Diagnostic and Interventional Catheters by Company (2 of 2) 71
  • Figure 3-20: Diagnostic and Interventional Guidewire by Company (1 of 3) 74
  • Figure 3-21: Diagnostic and Interventional Guidewire by Company (2 of 3) 74
  • Figure 3-22: Diagnostic and Interventional Guidewire by Company (3 of 3) 76
  • Figure 3-23: Introducer Sheath by Company (1 of 4) 77
  • Figure 3-24: Introducer Sheath by Company (2 of 4) 78
  • Figure 3-25: Introducer Sheath by Company (3 of 4) 79
  • Figure 3-26: Introducer Sheath by Company (4 of 4) 80
  • Figure 3-27: Vascular Closure Device by Company (1 of 2) 81
  • Figure 3-28: Vascular Closure Device by Company (2 of 2) 82
  • Figure 3-29: Transcatheter Embolization Devices by Company (1 of 2) 84
  • Figure 3-30: Transcatheter Embolization Devices by Company (2 of 2) 85
  • Figure 3-31: Peripheral IVUS Catheter by Company 86
  • Figure 3-32: Class 2 Device Recall RX ACCULINK Carotid Stent System 87
  • Figure 3-33: Class 2 Device Recall StarClose SE Vascular Closure System, Abbot 87
  • Figure 3-34: Class 2 Device Recall ClosureFast Micro Introducer Sheath Set, Argon Medical 88
  • Figure 3-35: Class 2 Device Recall Super ArrowFlex Percutaneous Sheath Introducer Sets, Arrow 88
  • Figure 3-36: Class 2 Device Recall Percutaneous Sheath Introducer Kit, Arrow 89
  • Figure 3-37: Class 2 Device Recall Super ArrowFlex(R) Percutaneous Sheath Introducer Set with Integral Hemostasis Valve/Side Port, Arrow 89
  • Figure 3-38: Class 2 Device Recall Arrow 89
  • Figure 3-39: Class 2 Device Recall Arrow Percutaneous Sheath Introducer Kits, Arrow 90
  • Figure 3-40: Class 2 Device Recall iCAST and Advanta 91
  • Figure 3-41: Class 2 Device Recall Denali Filter Femoral Delivery System, Bard Peripheral Vascular Inc 92
  • Figure 3-42: Class 2 Device Recall Denali Filter Jugular Subclavian Delivery System, Bard Peripheral Vascular Inc 92
  • Figure 3-43: Class 1 Device Recall Bard Peripheral Vascular 92
  • Figure 3-44: Class 2 Device Recall FLAIR Endovascular Stent Graft, Bard Peripheral Vascular Inc 93
  • Figure 3-45: Class 2 Device Recall, Boston Scientific 94
  • Figure 3-46: Class 1 Device Recall Boston Scientific 94
  • Figure 3-47: Class 2 Device Recall Boston Scientific Imager II Angiographic Catheter 95
  • Figure 3-48: Class 2 Device Recall IMAGER II Angiographic Catheters 95
  • Figure 3-49: Class 2 Device Recall Guider Softip XF 95
  • Figure 3-50: Class 1 Device Recall Boston Scientific 96
  • Figure 3-51: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath 96
  • Figure 3-52: Class 1 Device Recall Chariot" Guiding Sheath 96
  • Figure 3-53: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific 97
  • Figure 3-54: Class 2 Device Recall AngioJet Thrombectomy Set, Boston Scientific 97
  • Figure 3-55: Class 2 Device Recall Cardinal Health 98
  • Figure 3-56: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc 99
  • Figure 3-57: Class 2 Device Recall ViperWire Advance with Flextip Peripheral Atherectomy Guide Wire, Cardiovascular Systems Inc 99
  • Figure 3-58: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Cardiovascular Systems Inc 99
  • Figure 3-59: Class 2 Device Recall ViperWire Advance peripheral guide wire, Cardiovascular Systems Inc 100
  • Figure 3-60: Class 1 Device Recall Diamondback 360 Peripheral Orbital Atherectomy System 100
  • Figure 3-61: Class 2 Device Recall SlipCath Beacon Tip Catheter 101
  • Figure 3-62: Class 2 Device Recall CheckFlo Performer Introducer Set 101
  • Figure 3-63: Class 2 Device Recall Micropuncture CheckFlo Performer Introducer Set 101
  • Figure 3-64: Class 2 Device Recall CheckFlo Introducer HausdorfLock Atrial 102
  • Figure 3-65: Class 3 Device Recall Gunther Tulip Vena Cava Filter Set 102
  • Figure 3-66: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set 102
  • Figure 3-67: Class 2 Device Recall Cook Medical 103
  • Figure 3-68: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft 103
  • Figure 3-69: Class 1 Device Recall Zenith Alpha Thoracic Endovascular Graft 103
  • Figure 3-70: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter 104
  • Figure 3-71: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter 104
  • Figure 3-72: Class 1 Device Recall OptEase Vena Cava Filter, Cordis 104
  • Figure 3-73: Class 2 Device Recall Cordis S.M.A.R.T. Flex Vascular Stent System 105
  • Figure 3-74: Class 2 Device Recall Transhepatic Biliary Stent System 105
  • Figure 3-75: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System 106
  • Figure 3-76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft 106
  • Figure 3-77: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System 106
  • Figure 3-78: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft 106
  • Figure 3-79: Class 2 Device Recall AFX Endovascular AAA System, Endologix 107
  • Figure 3-80: Class 1 Device Recall IntraClude IntraAortic Occlusion Device 108
  • Figure 3-81: Class 2 Device Recall IntraClude(TM) IntraAortic Occlusion Device 108
  • Figure 3-82: Class 2 Device Recall Edwards Lifesciences IntraClude IntraAortic Occlusion Device 108
  • Figure 3-83: Class 2 Device Recall Corkscrew Catheter 108
  • Figure 3-84: Class 1 Device Recall CS100 IntraAortic Balloon Pump 109
  • Figure 3-85: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump 109
  • Figure 3-86: Class 1 Device Recall Cardiosave Hybrid IABP 109
  • Figure 3-87: Class 2 Device Recall Protege Rx Tapered Carotid Stent System, Eve Inc. 110
  • Figure 3-88: Class 1 Device Recall Covidien 110
  • Figure 3-89: Class 2 Device Recall PowerCross .018 OTW PTA Dilation Catheter, Medtronic 110
  • Figure 3-90: Class 2 Device Recall Ev3, Inc. (Medtronic) 111
  • Figure 3-91: Class 2 Device Recall Amphirion Deep OTW PTA Balloon Catheter, Medtronic 111
  • Figure 3-92: lass 2 Device Recall EV3 EverFiex" Selfexpanding Peripheral Stent System, Ev3 Inc. 112
  • Figure 3-93: Class 2 Device Recall Medtronic Aptus™ HeliFX™ Thoracic EndoAnchor™ System HeliFX Guide 42 mm, Medtronic 112
  • Figure 3-94: Class 2 Device Recall Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems, Medtronic 112
  • Figure 3-95: Class 2 Device Recall FIBERNET Embolic Protection System, Medtronic 113
  • Figure 3-96: Class 2 Device Recall Spectranetics TurboElite Laser Atherectomy Catheters, Spectranetics 114
  • Figure 3-97: Class 2 Device Recall Turbo Elite Atherectomy Catheter, Spectranetics 114
  • Figure 3-98: Class 2 Device Recall TurboPower, Spectranetics 114
  • Figure 3-99: Class 1 Device Recall Bridge Balloon Catheter 115
  • Figure 3-100: Class 1 Device Recall Bridge Balloon 115
  • Figure 3-101: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System 116
  • Figure 3-102: Class 2 Device Recall PINNACLE Introducer Sheath, Terumo 117
  • Figure 3-103: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System 117
  • Figure 3-104: Class 2 Device Recall DIAMONDBACK 360 Peripheral Orbital Atherectomy System 117
  • Figure 3-105: Class 1 Device Recall 7F Prelude Short Sheath Introducer, Merit 118
  • Figure 3-106: Class 2 Device Recall USE PTA 0.014 RX Catheter, Us Endovascular 118
  • Figure 3-107: Class 2 Device Recall Balloon Catheter, EXP Pharmaceutical Services Corp 118
  • Figure 3-108: Class 2 Device Recall IVUS Catheter, Volcano 119
  • Figure 3-109: Class 1 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular 119
  • Figure 3-110: Class 2 Device Recall Ovation Prime Abdominal Stent Graft System, TriVascular 119
  • Figure 3-111: Class 2 Device Recall MynxGrip Vascular Closure Device 120
  • Figure 3-112: Class 2 Device Recall Vascular closure device, EXP Pharmaceutical (OEM) 120
  • Figure 3-113: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease 121
  • Figure 3-114: Stella Supera Siberia 121
  • Figure 3-115: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease 122
  • Figure 3-116: Absolute Pro® MOMENTUM™ (MOMENTUM) 122
  • Figure 3-117: Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB) 123
  • Figure 3-118: Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (MOBILITY OE) 123
  • Figure 3-119: Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. (MOBILITY AP) 124
  • Figure 3-120: ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System 124
  • Figure 3-121: Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW) 125
  • Figure 3-122: "All Comers" Post Market Clinical Follow-up (PMCF) With Multi-LOC for flOw liMiting Outcomes (LOCOMOTIVE Extended) 125
  • Figure 3-123: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II) 126
  • Figure 3-124: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME) 126
  • Figure 3-125: The Jetstream (JET) Post-market Registry (JET) 127
  • Figure 3-126: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA) 127
  • Figure 3-127: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease 128
  • Figure 3-128: An Efficacy and Safety Study to Evaluate Ranger DEB 128
  • Figure 3-129: Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery 129
  • Figure 3-130: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL) 129
  • Figure 3-131: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 130
  • Figure 3-132: VIRTUS: An Evaluation of the Vici™ Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction (VIRTUS) 130
  • Figure 3-133: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon 131
  • Figure 3-134: Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) 131
  • Figure 3-135: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB) 132
  • Figure 3-136: Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon 132
  • Figure 3-137: Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB 133
  • Figure 3-138: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR) 133
  • Figure 3-139: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon 134
  • Figure 3-140: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 134
  • Figure 3-141: The Safety and Efficacy of an Extravascular, Water-Soluble Sealant 135
  • Figure 3-142: Zilver® PTX® V Clinical Study 136
  • Figure 3-143: Zilver Flex Post-Market Study in Japan 136
  • Figure 3-144: Zilver PTX Post-Market Study in Japan 136
  • Figure 3-145: Zilver® PTX® in China 137
  • Figure 3-146: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) 137
  • Figure 3-147: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE) 138
  • Figure 3-148: FORMAT Clinical Study 138
  • Figure 3-149: VIVO Clinical Study 139
  • Figure 3-150: Study of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or Occlusion 140
  • Figure 3-151: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN) 140
  • Figure 3-152: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon 141
  • Figure 3-153: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 141
  • Figure 3-154: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT) 142
  • Figure 3-155: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the FLEX Scoring Catheter Plus DCB (FORTEZ) 142
  • Figure 3-156: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA 143
  • Figure 3-157: IN.PACT Global Clinical Study 143
  • Figure 3-158: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease 144
  • Figure 3-159: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 144
  • Figure 3-160: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT) 145
  • Figure 3-161: Korean Multicenter Prospective Registry of In.PACT DEB for Isolated Popliteal Artery Disease (K-POP Study) 145
  • Figure 3-162: In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions (INPCTFLEXION) 146
  • Figure 3-163: IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA) (INPACT SFA II) 146
  • Figure 3-164: Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia (INPACT-DEEP) 147
  • Figure 3-165: Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease (INPACT SFA I) 147
  • Figure 3-166: The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population 148
  • Figure 3-167: EverFlex Post Approval Study (DURABILITY PAS) 148
  • Figure 3-168: Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" (PRIME) 149
  • Figure 3-169: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease 150
  • Figure 3-170: Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Intervention: REACH PVI (REACH PVI) 151
  • Figure 3-171: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) 151
  • Figure 3-172: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS) 152
  • Figure 3-173: TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions 152
  • Figure 3-174: ILLUMENATE Pivotal Post-Approval Study (PAS) 153
  • Figure 3-175: Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon (ILLUMENATE) 153
  • Figure 3-176: Comparison of Angioplasty/Drug Coated Balloon/Laser + Drug Coated Balloon for Femoropopliteal Artery In-stent Restenosis (INTACT) 154
  • Figure 3-177: Global Study of a Drug-coated Balloon to Treat Obstructive SFA and/or Popliteal Lesions (ILLUMENATE) 154
  • Figure 3-178: An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies (REX) 155
  • Figure 3-179: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) 156
  • Figure 3-180: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND) 157
  • Figure 3-181: Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon (PREVEIL) 157
  • Figure 3-182: Treatment of Patients With Lesions in the Superficial Femoral or Popliteal Arteries Using Kanshas Drug Coated Balloon (KANSHAS1) 158
  • Figure 3-183: Misago® RX Self-Expanding Peripheral Stent 158
  • Figure 3-184: In-Stent Restenosis Post-Approval Study 159
  • Figure 3-185: Evaluation of the GORE TIGRIS Vascular Stent (TIGRIS) 159
  • Figure 3-186: A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. (VBXFLEX) 160
  • Figure 3-187: Multi-center Study for Stent Graft System for Peripheral Artery (VJH 11-01) 160
  • Figure 3-188: Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels (EXPAND) 161
  • Figure 3-189: " Endarterectomy Combined With Optimal Medical Therapy (OMT) vs OMT Alone in Patients With Asymptomatic Severe Atherosclerotic Carotid Artery Stenosis at Higher-than-average Risk of Ipsilateral Stroke " (ACTRIS) 162
  • Figure 3-190: Carotid Endarterectomy and Carotid Artery Stenting in Brazil 162
  • Figure 3-191: Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease 163
  • Figure 3-192: Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty (FAVABED) 163
  • Figure 3-193: BIOLUX P-III BENELUX All-Comers Registry 164
  • Figure 3-194: BIOLUX P-III SPAIN All-Comers Registry 164
  • Figure 3-195: Drug Eluting Balloon for Early Fistula Failure Trial (DEBEFF) 164
  • Figure 3-196: Drug-Eluting Balloon in Arteriovenous Graft 165
  • Figure 3-197: Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions (ADCAT) 165
  • Figure 3-198: Drug-Coated Chocolate PTA Balloon in Patients With Peripheral Arterial Disease - The ENDURE Trial (ENDURE) 165
  • Figure 3-199: AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China 166
  • Figure 3-200: AcoArt Ⅱ/ BTK China: Drug-eluting Balloon for Below-The-Knee Angioplasty Evaluation in China 166
  • Figure 3-201: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (DRECOREST1) 167
  • Figure 3-202: Stella Supera Siberia 167
  • Figure 3-203: Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU) 168
  • Figure 3-204: Clinical Study of Passeo-18 Lux Balloon Catheter for the Treatment of Atherosclerotic Lesions(BIOLUX-P IV CHINA) 168
  • Figure 3-205: Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents (BIOFLEX-I) 168
  • Figure 3-206: Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System (OPEN) 169
  • Figure 3-207: Remedy, Biodegradable Peripheral Stent Registry 169
  • Figure 3-208: BIOLUX P-III All-Comers Passeo-18 Lux Registry 170
  • Figure 3-209: BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB) 170
  • Figure 4-1: Currency Exchange Rate, 2019 173
  • Figure 4-2: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (€M) (1 of 2) 175
  • Figure 4-3: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (€M) (2 of 2) 176
  • Figure 4-4: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (US$M) (1 of 2) 177
  • Figure 4-5: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 (US$M) (2 of 2) 178
  • Figure 4-6: Growth Rates by Segment, Peripheral Vascular Device Market, Europe, 2016 - 2026 (1 of 2) 183
  • Figure 4-7: Growth Rates by Segment, Peripheral Vascular Device Market, Europe, 2016 - 2026 (2 of 2) 184
  • Figure 4-8: Drivers and Limiters, Peripheral Vascular Device Market, Europe, 2019 188
  • Figure 4-9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 (1 of 2) 194
  • Figure 4-10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 (2 of 2) 195
  • Figure 4-11: SWOT Analysis, Abbott 209
  • Figure 4-12: SWOT Analysis, B. Braun 210
  • Figure 4-13: SWOT Analysis, Boston Scientific 211
  • Figure 4-14: SWOT Analysis, Cardinal Health 213
  • Figure 4-15: SWOT Analysis, Cook Medical 214
  • Figure 4-16: SWOT Analysis, Integra Lifesciences 215
  • Figure 4-17: SWOT Analysis, Maquet 216
  • Figure 4-18: SWOT Analysis, Medtronic 217
  • Figure 4-19: SWOT Analysis, Merit Medical 218
  • Figure 4-20: SWOT Analysis, Phillips 219
  • Figure 4-21: SWOT Analysis, Teleflex 220
  • Figure 4-22: SWOT Analysis, Terumo 221
  • Figure 4-23: SWOT Analysis, W.L. Gore 222

LIST OF CHARTS

  • Chart 1-1: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 3
  • Chart 1-2: Peripheral Vascular Device Market Overview, Europe, 2016 - 2026 3
  • Chart 4-1: Peripheral Vascular Device Market by Segment, Europe, 2016 - 2026 179
  • Chart 4-2: Peripheral Vascular Device Market Breakdown, Europe, 2019 180
  • Chart 4-3: Peripheral Vascular Device Market Breakdown, Europe, 2026 181
  • Chart 4-4: Growth Rates by Segment, Peripheral Vascular Device Device Market, Europe, 2016 - 2026 185
  • Chart 4-5: Leading Competitors, Peripheral Vascular Device Market, Europe, 2019 196
  • Chart 5-1: Country Profile, Germany, 2019 229
  • Chart 5-2: Country Profile, France, 2019 230
  • Chart 5-3: Country Profile, United Kingdom, 2019 231
  • Chart 5-4: Country Profile, Italy, 2019 232
  • Chart 5-5: Country Profile, Spain, 2019 233
  • Chart 5-6: Country Profile, Benelux, 2019 234
  • Chart 5-7: Country Profile, Scandinavia, 2019 235
  • Chart 5-8: Country Profile, Austria, 2019 236
  • Chart 5-9: Country Profile, Switzerland, 2019 237
  • Chart 5-10: Country Profile, Portugal, 2019 238
  • Chart 6-1: Bare-Metal Stent Procedures by Segment, Europe, 2016 - 2026 244
  • Chart 7-1: Peripheral Vascular Stent Market by Segment, Europe, 2016 - 2026 303
  • Chart 7-2: Peripheral Vascular Stent Market Breakdown, Europe, 2019 304
  • Chart 7-3: Peripheral Vascular Stent Market Breakdown, Europe, 2026 305
  • Chart 7-4: Peripheral Arterial Stent Market, Europe, 2016 - 2026 308
  • Chart 7-5: Bare-Metal Stent Market by Indication, Europe, 2016 - 2026 316
  • Chart 7-6: Total Bare-Metal Stent Market, Europe, 2016 - 2026 318
  • Chart 7-7: Bare-Metal Illiac Stent Market, Europe, 2016 - 2026 325
  • Chart 7-8: Bare-Metal Femoral-Popliteal Stent Market, Europe, 2016 - 2026 332
  • Chart 7-9: Bare-Metal Infra-Popliteal Stent Market, Europe, 2016 - 2026 339
  • Chart 7-10: Bare-Metal Renal Stent Market, Europe, 2016 - 2026 346
  • Chart 7-11: Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 353
  • Chart 7-12: Units Sold by Length, Bare-Metal Iliac Stent Market, Europe, 2016 - 2026 360
  • Chart 7-13: Units Sold by Length, Bare-Metal Lower Limb Stent Market, Europe, 2016 - 2026 362
  • Chart 7-14: Units Sold by Length, Bare-Metal Renal Stent Market, Europe, 2016 - 2026 364
  • Chart 7-15: Units Sold by Length, Bare-Metal Carotid Stent Market, Europe, 2016 - 2026 366
  • Chart 7-16: Covered Stent Market, Europe, 2016 - 2026 368
  • Chart 7-17: Drug-Eluting Stent Market, Europe, 2016 - 2026 376
  • Chart 7-18: Leading Competitors, Bare-Metal Stent Market, Europe, 2019 389
  • Chart 8-1: Total Peripheral Venous Stent Market, Europe, 2016 - 2026 394
  • Chart 8-2: Leading Competitors, Peripheral Venous Stent Market, Europe, 2019 404
  • Chart 9-1: PTA Balloon Catheter Market by Segment, Europe, 2016 - 2026 410
  • Chart 9-2: PTA Balloon Catheter Market Breakdown, Europe, 2019 411
  • Chart 9-3: PTA Balloon Catheter Market Breakdown, Europe, 2026 412
  • Chart 9-4: Total PTA Balloon Catheter Market, Europe, 2016 - 2026 414
  • Chart 9-5: Standard PTA Balloon Catheter Market, Europe, 2016 - 2026 421
  • Chart 9-6: High-Pressure PTA Balloon Catheter Market, Europe, 2016 - 2026 428
  • Chart 9-7: Large PTA Balloon Catheter Market, Europe, 2016 - 2026 435
  • Chart 9-8: Small PTA Balloon Catheter Market, Europe, 2016 - 2026 442
  • Chart 9-9: Specialty PTA Balloon Catheter Market, Europe, 2016 - 2026 449
  • Chart 9-10: Leading Competitors, PTA Balloon Catheter Market, Europe, 2019 456
  • Chart 10-1: Atherectomy Device Market, Europe, 2016 - 2026 461
  • Chart 10-2: Leading Competitors, Atherectomy Device Market, Europe, 2019 474
  • Chart 11-1: Chronic Total Occlusion Device Market by Segment, Europe, 2016 - 2026 478
  • Chart 11-2: Chronic Total Occlusion Device Market by Segment, Europe, 2019 479
  • Chart 11-3: Chronic Total Occlusion Device Market by Segment, Europe, 2026 480
  • Chart 11-4: Total CTO Device Market, Europe, 2016 - 2026 482
  • Chart 11-5: Recanalization CTO Device Market, Europe, 2016 - 2026 484
  • Chart 11-6: Re-Entry CTO Device Market, Europe, 2016 - 2026 486
  • Chart 11-7: Leading Competitors, Chronic Total Occlusion Device Market, Europe, 2019 491
  • Chart 12-1: Embolic Protection Device Market, Europe, 2016 - 2026 495
  • Chart 12-2: Leading Competitors, Embolic Protection Device Market, Europe, 2019 505
  • Chart 13-1: Stent Graft Market by Segment, Europe, 2016 - 2026 509
  • Chart 13-2: Stent Graft Market Breakdown, Europe, 2019 510
  • Chart 13-3: Stent Graft Market Breakdown, Europe, 2026 511
  • Chart 13-4: Total Stent Graft Market, Europe, 2016 - 2026 514
  • Chart 13-5: AAA Stent Graft Market, Europe, 2016 - 2026 521
  • Chart 13-6: TAA Stent Graft Market, Europe, 2016 - 2026 528
  • Chart 13-7: Fenestrated Stent Graft Market, Europe, 2016 - 2026 536
  • Chart 13-8: Leading Competitors, Stent Graft Market, Europe, 2019 549
  • Chart 14-1: Surgical Graft Market by Segment, Europe, 2016 - 2026 553
  • Chart 14-2: Surgical Graft Market Breakdown, Europe, 2019 554
  • Chart 14-3: Surgical Graft Market Breakdown, Europe, 2026 555
  • Chart 14-4: Total Surgical Graft Market, Europe, 2016 - 2026 557
  • Chart 14-5: Lower Limb Surgical Graft, Europe, 2016 - 2026 564
  • Chart 14-6: AV Access Surgical Graft Market, Europe, 2016 - 2026 571
  • Chart 14-7: Aorta Repair Surgical Graft Market by Segment, Europe, 2016 - 2026 579
  • Chart 14-8: Total Aorta Repair Surgical Graft Market, Europe, 2016 - 2026 581
  • Chart 14-9: AAA Surgical Graft Market, Europe, 2016 - 2026 588
  • Chart 14-10: TAA Surgical Graft Market, Europe, 2016 - 2026 595
  • Chart 14-11: Extra-Anatomical Surgical Graft Market, Europe, 2016 - 2026 602
  • Chart 14-12: Leading Competitors, Surgical Graft Market, Europe, 2019 614
  • Chart 15-1: AV Access Thrombectomy Device Market, Europe, 2016 - 2026 618
  • Chart 15-2: Leading Competitors, AV Access Thrombectomy Device Market, Europe, 2019 628
  • Chart 16-1: Inferior Vena Cava Filter Market, Europe, 2016 - 2026 632
  • Chart 16-2: Leading Competitors, Inferior Vena Cava Filter, Europe, 2019 643
  • Chart 17-1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2016 - 2026 647
  • Chart 17-2: Diagnostic and Interventional Catheter Market Breakdown, Europe, 2019 648
  • Chart 17-3: Diagnostic and Interventional Catheter Market Breakdown, Europe, 2026 649
  • Chart 17-4: Total Diagnostic and Interventional Catheter Market, Europe, 2016 - 2026 651
  • Chart 17-5: Diagnostic Catheter Market, Europe, 2016 - 2026 658
  • Chart 17-6: Interventional Catheter Market, Europe, 2016 - 2026 665
  • Chart 17-7: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2019 677
  • Chart 18-1: Standard and Hydrophilic Guidewire Market by Segment, Europe, 2016 - 2026 681
  • Chart 18-2: Standard and Hydrophilic Guidewire Market Breakdown, Europe, 2019 682
  • Chart 18-3: Standard and Hydrophilic Guidewire Market Breakdown, Europe, 2026 683
  • Chart 18-4: Total Standard and Hydrophilic Guidewire Market, Europe, 2016 - 2026 685
  • Chart 18-5: Standard Guidewire Market, Europe, 2016 - 2026 692
  • Chart 18-6: Hydrophilic Guidewire Graft Market, Europe, 2016 - 2026 699
  • Chart 18-7: Leading Competitors, Standard and Hydrophilic Guidewire Market, Europe, 2019 711
  • Chart 19-1: Introducer Sheath Market, Europe, 2016 - 2026 714
  • Chart 19-2: Leading Competitors, Introducer Sheath Market, Europe, 2019 724
  • Chart 20-1: Vascular Closure Device Market by Segment, Europe, 2016 - 2026 729
  • Chart 20-2: Vascular Closure Device Market Breakdown, Europe, 2019 730
  • Chart 20-3: Vascular Closure Device Market Breakdown, Europe, 2026 731
  • Chart 20-4: Vascular Closure Device Market by Approach, Europe, 2016 - 2026 734
  • Chart 20-5: Vascular Closure Device Market Breakdown, Europe, 2019 735
  • Chart 20-6: Vascular Closure Device Market Breakdown, Europe, 2026 736
  • Chart 20-7: Total Vascular Closure Device Market, Europe, 2016 - 2026 738
  • Chart 20-8: Invasive VCD Market by Device Type, Europe, 2016 - 2026 746
  • Chart 20-9: Invasive VCD Market, Europe, 2016 - 2026 748
  • Chart 20-10: Small Bore Invasive VCD Market, Europe, 2016 - 2026 755
  • Chart 20-11: Large Bore Invasive VCD Market, Europe, 2016 - 2026 763
  • Chart 20-12: Non-Invasive VCD Market, Europe, 2016 - 2026 770
  • Chart 20-13 Vascular Closure Device Market by Approach, Europe, 2016 - 2026 777
  • Chart 20-14: Femoral VCD Market, Europe, 2016 - 2026 779
  • Chart 20-15: Radial VCD Market, Europe, 2016 - 2026 786
  • Chart 20-16: Leading Competitors, VCD Market, Europe, 2019 798
  • Chart 21-1: Transcatheter Embolization Device Market by Segment, Europe, 2016 - 2026 804
  • Chart 21-2: Transcatheter Embolization Device Market Breakdown, Europe, 2019 805
  • Chart 21-3: Transcatheter Embolization Device Market Breakdown, Europe, 2026 806
  • Chart 21-4: Particle Embolic Device Market, Europe, 2016 - 2026 810
  • Chart 21-5: Coil Embolic Device Market, Europe, 2016 - 2026 818
  • Chart 21-6: Liquid Embolic Device Market, Europe, 2016 - 2026 825
  • Chart 21-7: Leading Competitors, Transcatheter Embolization Device Market, Europe, 2019 838
  • Chart 22-1: Drug-Coated Balloon Catheter Market, Europe, 2016 - 2026 842
  • Chart 23-1: Intravascular Lithotripsy Market, U.S., 2016 - 2026 852
  • Chart 24-1: Peripheral IVUS Catheter Market, U.S., 2016 - 2026 859
  • Chart 24-2: Leading Competitors, Peripheral IVUS Catheter Market, Europe, 2019 865

The European peripheral vascular device market was valued at about 1.3 billion Euro in 2019. This is expected to increase over the forecast period at a CAGR of 2.9% to reach about 1.6 billion Euro by 2026.

The growth of venous treatments in Europe is expected to accelerate in the coming years as clinical knowledge continues to develop and expertise in the medical community is diffused. While currently consolidated within select regions in the United Kingdom, Germany, France, Austria and Switzerland, venous treatment centers are expected to be developed across Europe to facilitate both the diagnosis and treatment of venous disease.

Treatment of peripheral arterial disease is slowly continuing to increase its penetration in the treatable population. As Europe continues to age, the total number of procedures is expected to grow over the forecast period. As reimbursement tensions continue, treatment techniques have continued to be refined towards the most cost effective, long-term option for patients.

The full report suite on the European market for peripheral vascular (PV) devices includes peripheral arterial stents, peripheral venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. There is also a series of appendices containing analyses on drug-coated balloons (DCBs), lithotripsy balloon catheters and peripheral intravascular ultrasound (IVUS) catheters.

TABLE OF CONTENTS I

LIST OF FIGURES XVII

LIST OF CHARTS XLIII

EXECUTIVE SUMMARY 1

  • EUROPEAN MARKET FOR PERIPHERAL VASCULAR DEVICES OVERVIEW 1
  • COMPETITIVE ANALYSIS 4
  • MARKET TRENDS 9
  • MARKET DEVELOPMENTS 13
  • PROCEDURE NUMBERS 14
  • MARKETS INCLUDED 16
  • VERSION HISTORY 18

RESEARCH METHODOLOGY 19

  • Step 1: Project Initiation & Team Selection 19
  • Step 2: Prepare Data Systems and Perform Secondary Research 22
  • Step 3: Preparation for Interviews & Questionnaire Design 24
  • Step 4: Performing Primary Research 25
  • Step 5: Research Analysis: Establishing Baseline Estimates 27
  • Step 6: Market Forecast and Analysis 28
  • Step 7: Identify Strategic Opportunities 30
  • Step 8: Final Review and Market Release 31
  • Step 9: Customer Feedback and Market Monitoring 32

DISEASE OVERVIEW 33

  • 2.1 BASIC ANATOMY 33
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS 34
    • 2.2.1 Aortic Aneurysms 34
    • 2.2.2 Atherosclerosis 35
    • 2.2.3 Peripheral Arterial Disease (PAD) 36
    • 2.2.4 Deep Vein Thrombosis (DVT) 37
    • 2.2.5 Pulmonary Embolism (PE) 38
  • 2.3 PATIENT DEMOGRAPHICS 40
    • 2.3.1 Aortic Aneurysms 40
    • 2.3.2 Atherosclerosis 40
    • 2.3.3 Peripheral Arterial Disease (PAD) 40
    • 2.3.4 Deep Vein Thrombosis (DVT) 41
    • 2.3.5 Pulmonary Embolism (PE) 41

PRODUCT PORTFOLIO 43

  • 3.1 INTRODUCTION 43
  • 3.2 PRODUCT PORTFOLIOS 43
    • 3.2.1 Peripheral Vascular Stent 43
    • 3.2.2 Venous Stent 46
    • 3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon 47
    • 3.2.4 Drug-Coated Balloon 51
    • 3.2.5 Atherectomy Device 53
    • 3.2.6 Chronic Total Occlusion (CTO) Device 55
    • 3.2.7 Intravascular Lithotripsy 57
    • 3.2.8 Surgical Graft 58
    • 3.2.9 Stent Graft 61
    • 3.2.10 Embolic Protection Device 63
    • 3.2.11 Peripheral Thrombus Management Device 65
    • 3.2.12 Inferior Vena Cava Filter 68
    • 3.2.13 Carotid Shunt 69
    • 3.2.14 Diagnostic and Interventional Catheters 70
    • 3.2.15 Diagnostic and Interventional Guidewire 73
    • 3.2.16 Introducer Sheath 77
    • 3.2.17 Vascular Closure Device (VCD) 81
    • 3.2.18 Transcatheter Embolization Device 83
    • 3.2.19 Peripheral IVUS Catheter 86
  • 3.3 REGULATORY ISSUES AND RECALLS 87
    • 3.3.1 Abbott 87
      • 3.3.1.1 Carotid Shunt 87
      • 3.3.1.2 Vascular Closure Device 87
    • 3.3.2 Argon Medical 88
      • 3.3.2.1 Introducer Sheaths 88
    • 3.3.3 Arrow International 89
      • 3.3.3.1 Introducer Sheaths 89
    • 3.3.4 Atrium Medical 91
      • 3.3.4.1 Peripheral Vascular Stent 91
    • 3.3.5 BD 92
      • 3.3.5.1 Inferior Vena Cava Filter 92
      • 3.3.5.2 Introducer Sheaths 92
      • 3.3.5.3 Stent Graft 93
    • 3.3.6 Boston Scientific 94
      • 3.3.6.1 Atherectomy Devices 94
      • 3.3.6.2 Diagnostic and Interventional Catheters 95
      • 3.3.6.3 Introducer Sheaths 96
      • 3.3.6.4 Peripheral Thrombus Management Devices 97
    • 3.3.7 Cardinal Health 98
      • 3.3.7.1 Vascular Closure Devices 98
    • 3.3.8 Cardiovascular System (C.S.I.) 99
      • 3.3.8.1 Atherectomy Devices 99
    • 3.3.9 Cook Medical 101
      • 3.3.9.1 Diagnostic and Interventional Catheters 101
      • 3.3.9.2 Introducer Sheaths 101
      • 3.3.9.3 Inferior Vena Cava Filters 102
      • 3.3.9.4 Peripheral Vascular Stents 103
      • 3.3.9.5 Stent Grafts 103
    • 3.3.10 Cordis (Cardinal Health) 104
      • 3.3.10.1 Diagnostic and Interventional Catheters 104
      • 3.3.10.2 Inferior Vena Cava Filters 104
      • 3.3.10.3 Peripheral Stents 105
    • 3.3.11 Endologix 106
      • 3.3.11.1 Stent Grafts 106
    • 3.3.12 Edwards Lifesciences 108
      • 3.3.12.1 Chronic Total Occlusion Devices 108
    • 3.3.13 Maquet 109
      • 3.3.13.1 PTA Balloons 109
    • 3.3.14 Medtronic 110
      • 3.3.14.1 Carotid Shunts 110
      • 3.3.14.2 Diagnostic and Interventional Catheters 110
      • 3.3.14.3 PTA Balloon Catheters 110
      • 3.3.14.4 Peripheral Stents 112
      • 3.3.14.5 Stent Grafts 112
      • 3.3.14.6 Transcatheter Embolization Devices 113
    • 3.3.15 Spectranetics (Philips) 114
      • 3.3.15.1 Atherectomy Devices 114
      • 3.3.15.2 Chronic Total Occlusion Devices 115
    • 3.3.16 Shockwave Medical, Inc. 116
      • 3.3.16.1 Intravascular Lithotripsy 116
    • 3.3.17 Terumo 117
      • 3.3.17.1 Introducer Sheaths 117
      • 3.3.17.2 PTA Balloon Catheters 117
    • 3.3.18 Other Companies 117
      • 3.3.18.1 Atherectomy Devices 117
      • 3.3.18.2 Introducer Sheaths 118
      • 3.3.18.3 PTA Balloon Catheters 118
      • 3.3.18.4 Peripheral IVUS Catheters 119
      • 3.3.18.5 Stent Grafts 119
      • 3.3.18.6 Vascular Closure Devices (VCD) 120
  • 3.4 CLINICAL TRIALS 121
    • 3.4.1 Abbott 121
      • 3.4.1.1 Peripheral Vascular Stent 121
      • 3.4.1.2 Other Peripheral Vascular Related Studies 124
    • 3.4.2 B. Braun 125
      • 3.4.2.1 Diagnostic and Interventional Catheters 125
      • 3.4.2.2 Peripheral Vascular Stent 125
    • 3.4.3 Boston Scientific 126
      • 3.4.3.1 Atherectomy Devices 126
      • 3.4.3.2 Drug-Coated Balloons 127
      • 3.4.3.3 Peripheral Vascular Stents 129
      • 3.4.3.4 Other Peripheral Vascular Related Studies 130
      • 3.4.3.5 Venous Stents 130
    • 3.4.4 C.R. Bard (BD) 131
      • 3.4.4.1 Diagnostic and Interventional Catheters 131
      • 3.4.4.2 Drug-Coated Balloons 131
      • 3.4.4.3 Venous Stents 133
      • 3.4.4.4 Other Peripheral Vascular Related Studies 134
    • 3.4.5 Cardinal Health 135
      • 3.4.5.1 Other Peripheral Vascular Related Studies 135
    • 3.4.6 Cook Medical 136
      • 3.4.6.1 Drug-Eluting Stents 136
      • 3.4.6.2 Inferior Vena Cava Filters 137
      • 3.4.6.3 Peripheral Vascular Stents 138
      • 3.4.6.4 Venous Stents 139
    • 3.4.7 Cordis (Cardinal Health) 140
      • 3.4.7.1 Peripheral Vascular Stents 140
    • 3.4.8 Medtronic 141
      • 3.4.8.1 Atherectomy Devices 141
      • 3.4.8.2 Drug-Coated Balloons 142
      • 3.4.8.3 Other Peripheral Vascular Related Studies 148
    • 3.4.9 Merit Medical 150
      • 3.4.9.1 Stent Grafts 150
    • 3.4.10 Philips/Spectranetics 151
      • 3.4.10.1 Atherectomy Devices 151
      • 3.4.10.2 Peripheral IVUS Catheters 151
      • 3.4.10.3 Spectranetics 152
        • 3.4.10.3.1 Drug-Coated Balloons 152
        • 3.4.10.3.2 Atherectomy Devices 155
    • 3.4.11 Shockwave Medical, Inc. 156
      • 3.4.11.1 Lithoplasty System 156
    • 3.4.12 Surmodics 157
      • 3.4.12.1 Drug-Coated Balloons 157
    • 3.4.13 Terumo 158
      • 3.4.13.1 Drug-Coated Balloons 158
      • 3.4.13.2 Peripheral Vascular Stents 158
    • 3.4.14 W.L. Gore 159
      • 3.4.14.1 Peripheral Vascular Stents 159
      • 3.4.14.2 Stent Grafts 160
      • 3.4.14.3 Expandable Balloons 161
    • 3.4.15 Other Companies 162
      • 3.4.15.1 Carotid Shunt / Endarterectomy 162
      • 3.4.15.2 Drug-Coated Balloons 163
      • 3.4.15.3 Peripheral Vascular Stents 167
      • 3.4.15.4 Other Peripheral Vascular Related Studies 170

PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW 171

  • 4.1 INTRODUCTION 171
    • 4.1.1 Atherosclerosis 171
    • 4.1.2 Peripheral Arterial Disease (PAD) 172
  • 4.2 CURRENCY EXCHANGE RATE 173
  • 4.3 MARKET OVERVIEW 174
  • 4.4 TREND ANALYSIS 182
  • 4.5 DRIVERS AND LIMITERS 186
    • 4.5.1 Market Drivers 186
    • 4.5.2 Market Limiters 187
  • 4.6 COMPETITIVE MARKET SHARE ANALYSIS 189
  • 4.7 COMPANY PROFILES 197
    • 4.7.1 Abbott 197
    • 4.7.2 Becton Dickinson (BD) 198
    • 4.7.3 Boston Scientific 199
    • 4.7.4 Cardinal Health 200
      • 4.7.4.1 Cordis (Cardinal Health) 200
    • 4.7.5 Cook Medical 201
    • 4.7.6 Maquet 202
    • 4.7.7 Medtronic 203
    • 4.7.8 Teleflex 205
    • 4.7.9 Terumo Interventional System (TIS) 206
    • 4.7.10 W.L. Gore 207
  • 4.8 SWOT ANALYSIS 208
    • 4.8.1 Abbott 209
    • 4.8.2 B. Braun 210
    • 4.8.3 Boston Scientific 211
    • 4.8.4 BD 212
    • 4.8.5 Cardinal Health 213
    • 4.8.6 Cook Medical 214
    • 4.8.7 Integra Lifesciences 215
    • 4.8.8 Maquet 216
    • 4.8.9 Medtronic 217
    • 4.8.10 Merit Medical 218
    • 4.8.11 Phillips 219
    • 4.8.12 Teleflex 220
    • 4.8.13 Terumo 221
    • 4.8.14 W.L. Gore 222
  • 4.9 MERGERS AND ACQUISITIONS 223

COUNTRY PROFILES 228

  • 5.1 INTRODUCTION 228
    • 5.1.1 Population 228
    • 5.1.2 Median Age 228
    • 5.1.3 GDP Per Capita 228
    • 5.1.4 Price Index 228
  • 5.2 GERMANY 229
  • 5.3 FRANCE 230
  • 5.4 UNITED KINGDOM 231
  • 5.5 ITALY 232
  • 5.6 SPAIN 233
  • 5.7 BENELUX 234
  • 5.8 SCANDINAVIA 235
  • 5.9 AUSTRIA 236
  • 5.10 SWITZERLAND 237
  • 5.11 PORTUGAL 238

PROCEDURE NUMBERS 239

  • 6.1 PROCEDURES 239
    • 6.1.1 Total Procedures 239
    • 6.1.2 Bare Metal Stent Procedures 241
      • 6.1.2.1 Iliac Bare Metal Stent Procedures 246
      • 6.1.2.2 Femoral Popliteal Bare Metal Stent Procedures 247
      • 6.1.2.3 Infra-Popliteal Bare Metal Stent Procedures 248
      • 6.1.2.4 Renal Bare Metal Stent Procedures 249
      • 6.1.2.5 Carotid Bare Metal Stent Procedures 250
    • 6.1.3 Venous Stenting Procedures 251
    • 6.1.4 Angioplasty Procedures 253
    • 6.1.5 Atherectomy Procedures 255
    • 6.1.6 Chronic Total Occlusion Procedures 257
    • 6.1.7 Embolic Protection Device Procedures 258
    • 6.1.8 Stent Graft Procedures 260
      • 6.1.8.1 AAA Stent Graft Procedures 261
      • 6.1.8.2 TAA Stent Graft Procedures 262
      • 6.1.8.3 Fenestrated Stent Graft Procedures 263
    • 6.1.9 Surgical Graft Procedures 264
      • 6.1.9.1 Lower Limb Surgical Graft Procedures 265
      • 6.1.9.2 AV Access Surgical Graft Procedures 266
      • 6.1.9.3 Aorta Repair Surgical Graft Procedures 267
        • 6.1.9.3.1 AAA Surgical Graft Procedures 269
        • 6.1.9.3.2 TAA Surgical Graft Procedures 270
      • 6.1.9.4 Extra-Anatomical Surgical Graft Procedures 271
    • 6.1.10 AV Access Thrombectomy Procedures 272
    • 6.1.11 Inferior Vena Cava Filter Procedures 274
    • 6.1.12 Vascular Closure Device Procedures 276
      • 6.1.12.1 Total Invasive Vascular Closure Device Procedures 278
        • 6.1.12.1.1 Invasive Small Bore Vascular Closure Device Procedures 280
        • 6.1.12.1.2 Invasive Large Bore Vascular Closure Device Procedures 281
      • 6.1.12.2 Non-Invasive Vascular Closure Device Procedures 282
      • 6.1.12.3 Vascular Closure Device Procedures by Approach 283
        • 6.1.12.3.1 Femoral Vascular Closure Device Procedures 284
        • 6.1.12.3.2 Radial Vascular Closure Device Procedures 285
    • 6.1.13 Transcatheter Embolization Procedures 286
      • 6.1.13.1 Particle Embolization Procedures 288
      • 6.1.13.2 Coil Embolization Procedures 289
      • 6.1.13.3 Liquid Embolization Procedures 290
    • 6.1.14 Drug-Coated Balloon Procedures 291
    • 6.1.16 Lithotripsy Procedures 293
    • 6.1.17 IVUS Procedures 294

PERIPHERAL ARTERIAL STENT MARKET 295

  • 7.1 INTRODUCTION 295
    • 7.1.1 Off-Label Use 296
    • 7.1.2 Covered Stents 296
    • 7.1.3 Drug-Eluting Stents 297
    • 7.1.4 Stent Length 298
  • 7.2 MARKET OVERVIEW 300
  • 7.3 MARKET ANALYSIS AND FORECAST 306
    • 7.3.1 Total Peripheral Arterial Stent Market 306
    • 7.3.2 Total Bare-Metal Stent Market 314
      • 7.3.2.1 Bare-Metal Illiac Stent Market 324
      • 7.3.2.2 Bare-Metal Femoral-Popliteal Stent Market 331
      • 7.3.2.3 Bare-Metal Infra-Popliteal Market 338
      • 7.3.2.4 Bare-Metal Renal Stent Market 345
      • 7.3.2.5 Bare-Metal Carotid Stent Market. 352
      • 7.3.2.6 Total Bare-Metal Stent Unit Analysis by Indication 359
    • 7.3.3 Covered Stent Market 367
    • 7.3.4 Drug-Eluting Stent Market 374
  • 7.4 DRIVERS AND LIMITERS 382
    • 7.4.1 Market Drivers 382
    • 7.4.2 Market Limiters 383
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 385

PERIPHERAL VENOUS STENT MARKET 390

  • 8.1 INTRODUCTION. 390
  • 8.2 MARKET ANALYSIS AND FORECAST 392
  • 8.3 DRIVERS AND LIMITERS 400
    • 8.3.1 Market Drivers 400
    • 8.3.2 Market Limiters 400
  • 8.4 COMPETITIVE MARKET SHARE ANALYSIS 402

PTA BALLOON CATHETER MARKET 405

  • 9.1 INTRODUCTION. 405
    • 9.1.1 Types of PTA Balloon Catheters 405
  • 9.2 MARKET OVERVIEW 407
  • 9.3 MARKET ANALYSIS AND FORECAST 413
    • 9.3.1 Total PTA Balloon Catheter Market 413
    • 9.3.2 Standard PTA Balloon Catheter Market 420
    • 9.3.3 High-Pressure PTA Balloon Catheter Market 427
    • 9.3.4 Large PTA Balloon Catheter Market 434
    • 9.3.5 Small PTA Balloon Catheter Market 441
    • 9.3.6 Specialty PTA Balloon Catheter Market 448
  • 9.4 DRIVERS AND LIMITERS 450
    • 9.4.1 Market Drivers 450
    • 9.4.2 Market Limiters 451
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 452

ATHERECTOMY DEVICE MARKET 457

  • 10.1 INTRODUCTION 457
  • 10.2 MARKET ANALYSIS AND FORECAST 459
  • 10.3 DRIVERS AND LIMITERS 467
    • 10.3.1 Market Drivers 467
    • 10.3.2 Market Limiters 468
  • 10.4 COMPETITIVE MARKET SHARE ANALYSIS 470

CHRONIC TOTAL OCCLUSION DEVICE MARKET 475

  • 11.1 INTRODUCTION 475
  • 11.2 MARKET OVERVIEW 476
  • 11.3 MARKET ANALYSIS AND FORECAST 481
    • 11.3.1 Total Chronic Total Occlusion (CTO) Device Market 481
    • 11.3.2 Recanalization CTO Device Market 483
    • 11.3.3 Re-Entry CTO Device Market 485
  • 11.4 DRIVERS AND LIMITERS 487
    • 11.4.1 Market Drivers 487
    • 11.4.2 Market Limiters 488
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS 489

EMBOLIC PROTECTION DEVICE MARKET 492

  • 12.1 INTRODUCTION 492
    • 12.1.1 Protection Mechanism 492
    • 12.1.2 Filter Basket 492
    • 12.1.2 Distal Balloon Occlusion 493
    • 12.1.4 Flow Redirection 493
  • 12.2 MARKET ANALYSIS AND FORECAST 494
  • 12.3 DRIVERS AND LIMITERS 501
    • 12.3.1 Market Drivers 501
    • 12.3.2 Market Limiters 501
  • 12.4 COMPETITIVE MARKET SHARE ANALYSIS 503

STENT GRAFT MARKET 506

  • 13.1 INTRODUCTION 506
  • 13.2 MARKET OVERVIEW 507
  • 13.3 MARKET ANALYSIS AND FORECAST 512
    • 13.3.1 Total Stent Graft Market 512
    • 13.3.2 AAA Stent Graft Market 520
    • 13.3.3 TAA Stent Graft Market 527
    • 13.3.4 Fenestrated Stent Graft 534
  • 13.4 DRIVERS AND LIMITERS 542
    • 13.4.1 Market Drivers 542
    • 13.4.2 Market Limiters 543
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS 545

SURGICAL GRAFT MARKET 550

  • 14.1 INTRODUCTION 550
  • 14.2 MARKET OVERVIEW 551
  • 14.3 MARKET ANALYSIS AND FORECAST 556
    • 14.3.1 Total Surgical Graft Market. 556
    • 14.3.2 Lower Limb Surgical Graft Market 563
    • 14.3.3 AV Access Surgical Graft Market 570
    • 14.3.4 Total Aorta Repair Surgical Graft Market 577
      • 14.3.4.1 AAA Surgical Graft Market 587
      • 14.3.4.2 TAA Surgical Graft Market 594
    • 14.3.5 Extra-Anatomical Surgical Graft Market 601
  • 14.4 DRIVERS AND LIMITERS 608
    • 14.4.1 Market Drivers 608
    • 14.4.2 Market Limiters 609
  • 14.5 COMPETITIVE MARKET SHARE ANALYSIS 611

AV ACCESS THROMBECTOMY DEVICE MARKET 615

  • 15.1 INTRODUCTION 615
    • 15.1.1 Other Peripheral Applications of Thrombectomy Devices 615
  • 15.2 MARKET ANALYSIS AND FORECAST 617
  • 15.3 DRIVERS AND LIMITERS 624
    • 15.3.1 Market Drivers 624
    • 15.3.2 Market Limiters 624
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS 626

INFERIOR VENA CAVA FILTER MARKET 629

  • 16.1 INTRODUCTION 629
  • 16.2 MARKET ANALYSIS AND FORECAST 631
  • 16.3 DRIVERS AND LIMITERS 638
    • 16.3.1 Market Drivers 638
    • 16.3.2 Market Limiters 638
  • 16.4 COMPETITIVE MARKET SHARE ANALYSIS 640

DIAGNOSTIC AND INTERVENTIONAL CATHETER MARKET 644

  • 17.1 INTRODUCTION 644
  • 17.2 MARKET OVERVIEW 645
  • 17.3 MARKET ANALYSIS AND FORECAST 650
    • 17.3.1 Total Diagnostic and Interventional Catheter Market 650
    • 17.3.2 Diagnostic Catheter Market 657
    • 17.3.3 Interventional Catheter Market 664
  • 17.4 DRIVERS AND LIMITERS 671
    • 17.4.1 Market Drivers 671
    • 17.4.2 Market Limiters 672
  • 17.5 COMPETITIVE MARKET SHARE ANALYSIS 674

STANDARD AND HYDROPHILIC GUIDEWIRE MARKET 678

  • 18.1 INTRODUCTION 678
  • 18.2 MARKET OVERVIEW 679
  • 18.3 MARKET ANALYSIS AND FORECAST 684
    • 18.3.1 Total Standard and Hydrophilic Guidewire Market 684
    • 18.3.2 Standard Guidewire Market 691
    • 18.3.3 Hydrophilic Guidewire Market 698
  • 18.4 DRIVERS AND LIMITERS 705
    • 18.4.1 Market Drivers 705
    • 18.4.2 Market Limiters 705
  • 18.5 COMPETITIVE MARKET SHARE ANALYSIS 708

INTRODUCER SHEATH MARKET 712

  • 19.1 INTRODUCTION 712
  • 19.2 MARKET ANALYSIS AND FORECAST 713
  • 19.3 DRIVERS AND LIMITERS 720
    • 19.3.1 Market Drivers 720
    • 19.3.2 Market Limiters 720
  • 19.4 COMPETITIVE MARKET SHARE ANALYSIS 722

VASCULAR CLOSURE DEVICE MARKET 725

  • 20.1 INTRODUCTION 725
  • 20.2 MARKET OVERVIEW 727
    • 20.2.1 Vascular Closure Device Market Overview by Device Type 727
    • 20.2.2 Vascular Closure Device Market Overview by Approach 732
  • 20.3 MARKET ANALYSIS AND FORECAST 737
    • 20.3.1 Total Vascular Closure Device Market 737
    • 20.3.2 Vascular Closure Device Market by Device Type 744
      • 20.3.2.1 Invasive VCD Market 744
        • 20.3.2.1.1 Small Bore Invasive VCD Market 754
        • 20.3.2.1.2 Large Bore Invasive VCD Market 761
      • 20.3.2.2 Non-Invasive VCD Market 769
    • 20.3.3 Vascular Closure Device Market by Approach 776
      • 20.3.3.1 Femoral VCD Market 778
      • 20.3.3.2 Radial VCD Market 785
  • 20.4 DRIVERS AND LIMITERS 792
    • 20.4.1 Market Drivers 792
    • 20.4.2 Market Limiters 793
  • 20.5 COMPETITIVE MARKET SHARE ANALYSIS 795

TRANSCATHETER EMBOLIZATION DEVICE MARKET 799

  • 21.1 INTRODUCTION 799
    • 21.1.1 Particle Embolic Devices 799
    • 21.1.2 Coil Embolic Devices 800
    • 21.1.3 Liquid Embolic Devices 800
  • 21.2 MARKET OVERVIEW 802
  • 21.3 MARKET ANALYSIS AND FORECAST 807
    • 21.3.1 Particle Embolic Device Market 807
    • 21.3.2 Coil Embolic Device Market 816
    • 21.3.3 Liquid Embolic Device Market 824
  • 21.4 DRIVERS AND LIMITERS 831
    • 21.4.1 Market Drivers 831
    • 21.4.2 Market Limiters 831
  • 21.5 COMPETITIVE MARKET SHARE ANALYSIS 834

APPENDIX I: DRUG-COATED BALLOON CATHETER MARKET 839

  • 22.1 MARKET ANALYSIS AND FORECAST 839
  • 22.2 DRIVERS AND LIMITERS 848
    • 22.2.1 Market Drivers 848
    • 22.2.2 Market Limiters 848

APPENDIX II: INTRAVASCULAR LITHOTRIPSY MARKET 849

  • 23.1 INTRODUCTION 849
  • 23.2 MARKET ANALYSIS AND FORECAST 851
  • 23.3 DRIVERS AND LIMITERS 853
    • 23.3.1 Market Drivers 853
    • 23.3.2 Market Limiters 853
  • 23.4 COMPETITIVE MARKET SHARE ANALYSIS 855

APPENDIX III: PERIPHERAL IVUS CATHETER MARKET 856

  • 24.1 INTRODUCTION 856
  • 24.2 MARKET ANALYSIS AND FORECAST 857
  • 24.3 DRIVERS AND LIMITERS 860
    • 24.3.1 Market Drivers 860
    • 24.3.2 Market Limiters 861
  • 24.4 COMPETITIVE MARKET SHARE ANALYSIS 863

ABBREVIATIONS 866

Back to Top
전화 문의
F A Q